Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
New Clinical and Preclinical Findings Support Continued Development of MTX-101 for Type 1 Diabetes...
Read story
Half-Life-Extended Bispecific Antibody Advances Into Clinical Testing for Mild-to-Moderate Asthma...
Read story
Pfizer Inc. presented detailed results from an ongoing phase 2 study investigating tilrekimig (PF-07...
Read story
Clear Scientific, Inc. today announced positive top-line results from its Phase 2 trial of CS-1103,...
Read story
AnnJi Pharmaceutical Co., Ltd. (AnnJi, TPEx: 7754), a clinical-stage drug development company focuse...
Read storyPage 1 of 2